Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Seminars in Vascular Surgery|September 8, 2025
Navigating treatment decisions for CLTI in older adults: Primary amputation vs revascularizationShannon N Radomski, Courtenay M Holscher
Seminars in Vascular Surgery|November 29, 2023
Prevalence and outcomes of select rare vascular conditions in females: A descriptive reviewRebecca Sorber, Caitlin J Bowen, Shannon N Radomski, et al.
Annals of Surgical Oncology|December 3, 2023
Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)Yusuf Ciftci, Shannon N Radomski, Fabian M Johnston, et al.
Annals of Surgical Oncology|January 22, 2025
Predicting Postoperative Infection After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with SplenectomyNolan M Winicki, Shannon N Radomski, Yusuf Ciftci, et al.
Annals of Surgical Oncology|September 4, 2024
Triphasic Learning Curve of Cytoreductive Surgery with Hyperthermic Intraperitoneal ChemotherapyYusuf Ciftci, Shannon N Radomski, Blake A Johnson, et al.
Annals of Surgical Oncology|May 22, 2024
Adoption of an Enhanced Recovery After Surgery Protocol Increases Cost of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy and Does not Improve OutcomesYusuf Ciftci, Shannon N Radomski, Blake A Johnson, et al.
Surgery|March 17, 2024
Mortality risk prediction for primary appendiceal cancerNolan M Winicki, Shannon N Radomski, Yusuf Ciftci, et al.
Annals of Surgical Oncology|January 4, 2024
Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic CancersShannon N Radomski, Matthew Dunworth, Junior J West, et al.
Journal of Surgical Oncology|July 14, 2023
Simultaneous resection of colorectal cancer and synchronous colorectal liver metastases: A risk stratified analysis of the NSQIP databaseShannon N Radomski, Sophia Y Chen, Miloslawa Stem, et al.
Journal of Surgical Oncology|September 9, 2022
Feasibility of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced peritoneal surface tumors during the COVID-19 pandemic: A single-institution experienceShannon N Radomski, Isabella Florissi, Hamza Khan, et al.
Pageof 4